The blood culture tests market globally reached USD 6.48 billion in 2022 and is projected to reach USD 12.95 billion in 2032, with a revenue compound annual growth rate (CAGR) of 8% during the forecast period. The growth of the market is primarily driven by the increasing prevalence of infectious diseases, the growing need for early and accurate diagnosis, and the rising adoption of automated...